<DOC>
	<DOCNO>NCT00006097</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase I/II trial study effectiveness CC-1088 treating patient chronic lymphocytic leukemia respond previous therapy .</brief_summary>
	<brief_title>Chemotherapy Treating Patients With Chronic Lymphocytic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : I . Determine toxicity CC-1088 patient refractory , progressive , B-cell chronic lymphocytic leukemia . II . Determine response rate treatment patient . OUTLINE : Patients receive oral CC-1088 three time day 28 day . Treatment continue absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : A total 11-20 patient accrue study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm refractory , progressive , Bcell chronic lymphocytic leukemia Failed prior first line therapy chlorambucil fludarabine ( equivalent ) Progressive disease define least one following : Greater 50 % increase sum product least 2 lymph node two consecutive determination 2 week apart ( least one lymph node must great 2 cm ) Appearance new palpable lymph node At least 50 % increase size previously palpable liver spleen Appearance palpable hepatomegaly splenomegaly previously present At least 50 % increase absolute lymphocyte count least 5,000/mm3 Transformation aggressive histology ( e.g. , Richter 's prolymphocytic leukemia ) High risk OR Intermediate risk active disease , define follow : Greater 10 % weight loss Extreme fatigue Fevers great 100.5 Fahrenheit great 2 week without infection Night sweat Splenomegaly great 6 cm Lymphadenopathy great 10 cm Lymphocytosis double time le 6 month PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG Zubrod 02 Life expectancy : Not specify Hematopoietic : See Disease Characteristics Hepatic : Bilirubin great 2.5 time upper limit normal ( ULN ) ALT AST great 2.5 time ULN Renal : Creatinine great 2.0 mg/dL Other : Not pregnant Negative pregnancy test Fertile patient must use effective contraception 2 week study PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2001</verification_date>
	<keyword>refractory chronic lymphocytic leukemia</keyword>
	<keyword>B-cell chronic lymphocytic leukemia</keyword>
</DOC>